Ledger.Open graph →

SEC Form D · Amendment · filed February 6, 2019

Ocuphire Pharma, Inc

Offering

$10.0M

Sold

$1.8M

Exemption

Rule 506(b)

Industry

Biotechnology

Location

WEST BLOOMFIELD, MI

Type

—

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (9)

Alan Meyer · West Bloomfield, MIDirector Mina Sooch · West Bloomfield, MIExec · Director Sean Ainsworth · West Bloomfield, MIDirector Adam K. Allen · HOUSTON, TXDirector Carson K. Mcdaniel · HOUSTON, TXDirector David K. Oelfke · HOUSTON, TXExec · Director Nicholas M. Look · Ladera Ranch, CADirector Matt F. Lopez · Ladera Ranch, CADirector Matthew J. Aiello · Crownsville, MDExec · Director

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗